Exploring Considerations With Direct Oral Anticoagulants For Nonvalvular Atrial Fibrillation
Exploring Considerations With Direct Oral Anticoagulants For Nonvalvular Atrial Fibrillation reveals several interesting facts.
- Date: May 25, 2021 Presenters: Arthur Allen, PharmD, CACP, Geoffrey Barnes, MD, MSc, Adam Cuker, MD, MS, Ghadeer ...
- Michael A. Evans, BS, RPh, explores the advantages and limitations of treating patients with
- Direct Oral Anticoagulants
- A majority of
- Mintu Turakhia, MD, MAS, discusses the difference in
In-Depth Information on Considerations With Direct Oral Anticoagulants For Nonvalvular Atrial Fibrillation
Rajat Deo, MD, explains his protocol for monitoring In this segment, Rajat Deo, MD, discusses physician Rajat Deo, MD, highlights the use and appropriateness of ... Michael B. Bottorff, PharmD, remarks on the differentiation of
Direct oral anticoagulants
Stay tuned for more updates related to Considerations With Direct Oral Anticoagulants For Nonvalvular Atrial Fibrillation.